Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Revenue

Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 434.47M CNY in the quarter ending June 30, 2026, with 31.30% growth. This brings the company's total for the last twelve months to 4.42B, up 256.98% year-over-year. In the year 2025, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 4.20B with 251.81% growth. That makes Sunshine Guojian Pharmaceutical (Shanghai) the 9,651st largest company in the world by revenue and 1,535th in China.

• Revenue (ttm): 4.42B
• Revenue Growth: +256.98%
• P/S Ratio: 6.51
• Revenue / Employee: 4.37M
• Employees: 1,023
• Market Cap: 28.90B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Other Countries and Regions 2.84B 68.1%
• Mainland China 1.34B 31.9%

Fiscal year ended Dec 31, 2025 See the full SHA:688336 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.20B	3.01B	251.81%
Dec 31, 2024	1.19B	179.53M	17.70%
Dec 31, 2023	1.01B	188.54M	22.84%
Dec 31, 2022	825.49M	-103.32M	-11.12%
Dec 31, 2021	928.81M	273.80M	41.80%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error